Free Trial
NASDAQ:INNV

InnovAge (INNV) Stock Price, News & Analysis

$5.97
-0.20 (-3.24%)
(As of 10/17/2024 ET)

About InnovAge Stock (NASDAQ:INNV)

Key Stats

Today's Range
$5.81
$6.15
50-Day Range
$5.34
$6.36
52-Week Range
$3.52
$6.61
Volume
21,381 shs
Average Volume
38,030 shs
Market Capitalization
$811.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.50
Consensus Rating
Hold

Company Overview

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

InnovAge Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
10th Percentile Overall Score

INNV MarketRank™: 

InnovAge scored higher than 10% of companies evaluated by MarketBeat, and ranked 972nd out of 1,012 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InnovAge has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    InnovAge has only been the subject of 1 research reports in the past 90 days.

  • Read more about InnovAge's stock forecast and price target.
  • Earnings Growth

    Earnings for InnovAge are expected to grow in the coming year, from ($0.01) to $0.09 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InnovAge is -37.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InnovAge is -37.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    InnovAge has a P/B Ratio of 2.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about InnovAge's valuation and earnings.
  • Percentage of Shares Shorted

    1.49% of the float of InnovAge has been sold short.
  • Short Interest Ratio / Days to Cover

    InnovAge has a short interest ratio ("days to cover") of 6.4.
  • Change versus previous month

    Short interest in InnovAge has recently increased by 1.62%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    InnovAge does not currently pay a dividend.

  • Dividend Growth

    InnovAge does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.49% of the float of InnovAge has been sold short.
  • Short Interest Ratio / Days to Cover

    InnovAge has a short interest ratio ("days to cover") of 6.4.
  • Change versus previous month

    Short interest in InnovAge has recently increased by 1.62%, indicating that investor sentiment is decreasing.
  • News Sentiment

    InnovAge has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for InnovAge this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added InnovAge to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InnovAge insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $26,013.00 in company stock.

  • Percentage Held by Insiders

    Only 0.41% of the stock of InnovAge is held by insiders.

  • Percentage Held by Institutions

    Only 12.26% of the stock of InnovAge is held by institutions.

  • Read more about InnovAge's insider trading history.
Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

INNV Stock News Headlines

InnovAge (NASDAQ:INNV) Coverage Initiated at KeyCorp
[Urgent] Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.
See More Headlines

INNV Stock Analysis - Frequently Asked Questions

InnovAge's stock was trading at $6.00 at the start of the year. Since then, INNV shares have decreased by 0.5% and is now trading at $5.97.
View the best growth stocks for 2024 here
.

InnovAge Holding Corp. (NASDAQ:INNV) released its quarterly earnings results on Tuesday, September, 10th. The company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. The company earned $199.40 million during the quarter, compared to analysts' expectations of $190.19 million. InnovAge had a negative net margin of 2.79% and a negative trailing twelve-month return on equity of 7.43%.

InnovAge (INNV) raised $301 million in an IPO on Thursday, March 4th 2021. The company issued 16,700,000 shares at a price of $17.00-$19.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup served as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers.

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
9/10/2024
Today
10/17/2024
Next Earnings (Estimated)
11/05/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:INNV
Fax
N/A
Employees
2,350
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.50
High Stock Price Target
$7.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+8.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-21,340,000.00
Pretax Margin
-2.86%

Debt

Sales & Book Value

Annual Sales
$763.86 million
Book Value
$2.04 per share

Miscellaneous

Free Float
135,065,000
Market Cap
$811.85 million
Optionable
Optionable
Beta
0.39
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NASDAQ:INNV) was last updated on 10/17/2024 by MarketBeat.com Staff
From Our Partners